» Articles » PMID: 16012760

Galectin-9 As a Regulator of Cellular Adhesion in Human Oral Squamous Cell Carcinoma Cell Lines

Overview
Journal Int J Mol Med
Specialty Genetics
Date 2005 Jul 14
PMID 16012760
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Oral squamous cell carcinomas (OSCCs), a major public health problem worldwide, are the most common neoplasms of the head and neck. The most important prognostic indicator for patients with OSCC is metastasis to cervical lymph nodes or distant organs. Galectin-9 is correlated with cellular adhesion and aggregation in melanoma cells. To investigate expression levels of galectin-9 mRNA and protein, we performed qRT-PCR and Western blot analyses on OSCC cell lines (Ca9-22, HSC-2, and HSC-3) and normal oral keratinocytes (NOKs). Galectin-9 mRNA and protein were commonly down-regulated in OSCC cell lines compared with NOKs. We further analyzed Ca9-22, which had the lowest expression of galectin-9. We then transfected the galectin-9 cDNA into Ca9-22 cells to examine whether overexpression of galectin-9 increases cellular adhesion in vitro. An adhesion assay using a fibronectin and collagen I coating plate revealed an increased cellular adherence ratio in overexpressed galectin-9 cells compared with nontransfected cells (p < 0.05). The data suggest that galectin-9 is correlated with oral cancer cell-matrix interactions and may therefore play an important role in the metastasis of OSCCs.

Citing Articles

Looking Beyond Checkpoint Inhibitor Monotherapy: Uncovering New Frontiers for Pancreatic Cancer Immunotherapy.

Giurini E, Ralph O, Pappas S, Gupta K Mol Cancer Ther. 2024; 24(1):18-32.

PMID: 39311547 PMC: 11694065. DOI: 10.1158/1535-7163.MCT-24-0311.


A new emerging target in cancer immunotherapy: Galectin-9 (LGALS9).

Lv Y, Ma X, Ma Y, Du Y, Feng J Genes Dis. 2023; 10(6):2366-2382.

PMID: 37554219 PMC: 10404877. DOI: 10.1016/j.gendis.2022.05.020.


Galectin-9 expression on tumour-associated immune cells is associated with favourable clinicopathological features and better outcomes in oral squamous cell carcinoma.

Peksa R, Kunc M, Piatek M, Radecka B, Jereczek-Fossa B, Starzynska A Contemp Oncol (Pozn). 2023; 27(1):22-27.

PMID: 37266336 PMC: 10230243. DOI: 10.5114/wo.2023.127142.


Galectin-9 in Gastroenterological Cancer.

Morishita A, Oura K, Tadokoro T, Shi T, Fujita K, Tani J Int J Mol Sci. 2023; 24(7).

PMID: 37047155 PMC: 10094448. DOI: 10.3390/ijms24076174.


Aberrant GIMAP2 expression affects oral squamous cell carcinoma progression by promoting cell cycle and inhibiting apoptosis.

Komatsu M, Saito K, Miyamoto I, Koike K, Iyoda M, Nakashima D Oncol Lett. 2022; 23(2):49.

PMID: 34992682 PMC: 8721858. DOI: 10.3892/ol.2021.13167.